AMA report: drug shortages a public health problem — 3 things to know

Drug shortages are a major public health issue, according to an American Medical Association Council on Science and Public Health report.

Here are three things to know:

1. The AMA supports authorizing the Secretary of the U.S. Department of Health and Human Services Reference Committee to expedite facility inspections and the review of drug applications, manufacturing changes and supplements that would help prevent or mitigate a drug shortage.

2. The AMA will push Congress and/or the FDA to require drug manufacturers to have a strategy to avert shortages.

3. According to an American Society of Anesthesiologists member survey, 98 percent of respondents regularly experience anesthesia drug shortages at their institutions, and 95 percent say the shortages adversely affect patient care.

More articles on supply chain:

Boston Scientific declines to comment on potential Stryker acquisition — 4 insights

Stryker seeks 12-year tax abatement for $92M expansion — 6 notes

German medical device manufacturer acquires Precision Medical Products — 5 highlights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers